ericsson.com
Your location is listed as Global
Login

Ericsson and Brighter pioneer IoT solution for diabetes treatments

  • Ericsson and its partner, Brighter, commercially introduce Actiste®, the world’s first complete IoT-health solution for monitoring and treating insulin-dependent diabetes
  • The solution is initially being introduced in United Arab Emirates (UAE) where approximately 480.000 insulin-dependent people and could benefit from using Actiste®
  • Ericsson’s IoT Accelerator provides Actiste® with consistent IoT connectivity management and a single dashboard, giving Brighter a unified view of devices regardless of location

Press release  |  Oct 10, 2019 12:56 (GMT +00:00)

IoT Digital transformation   #IoTDeviceManagement #ConnectivityManagement #IoTplatform

Ericsson (NASDAQ: ERIC) and its partner Brighter, a Swedish health-tech company focused on improving chronic disease management, have introduced Actiste®, the world's first complete IoT-health solution for monitoring and treating insulin-dependent diabetes. The introduction of the commercially-ready solution was announced October 7, 2019 at GITEX in Dubai.  Brighter is now ready to deliver Actiste® Diabetes Management as a Service in the UAE and the wider Gulf Cooperation Council (GCC) with cross-border mobile connectivity to be provided by leading communication service providers.

Actiste® brings together all required functions into a single connected device: blood sampling, blood glucose measurement and insulin injection. The device is delivered as part of a subscription service, designed to simplify patient’s everyday life and optimize and improve treatments. The total number of people living with diabetes in the UAE is currently 1.2 million, according to The International Diabetes Federation (IDF), of which approximately 480.000 are insulin-dependent and could benefit from Brighter’s Actiste service.

Henrik Norström, CEO, Brighter AB, says: “By partnering with Ericsson, we are able to offer a truly seamless customer experience. No matter where in the world patients decide to go, their generated health and treatment data will always be securely stored and available to improve their treatments.”

Fadi Pharaon, President of Ericsson Middle East and Africa, says: “This is an important milestone for how connectivity can transform people’s lives for the better. Our global partnership with Brighter has now reached a stage of real deliveries to the market, utilizing the global connectivity service based on our IoT Accelerator. The result is an enhanced healthcare industry in the UAE and wider GCC, and an improved quality of life for diabetes patients.”

The cellular-enabled, Actiste® devices are managed by Ericsson’s IoT Accelerator and securely connected by leading communications service providers to deliver a consistent level of service and a single dashboard. This provides Brighter with a unified view regardless of where those devices are deployed in the world.

Ericsson’s IoT Accelerator is used by 35 telecom service providers worldwide to provide managed connectivity services to over 4,500 enterprises in more than 100 countries. It enables enterprises to easily and cost-effectively manage IoT devices on a national, regional or global scale with full control throughout the entire IoT device lifecycle.


NOTES TO EDITORS:

Ericsson’s IoT platform – IoT Accelerator

Brighter IoT case - IoT Connectivity Management as a Service

FOLLOW US:

Subscribe to Ericsson press releases here.
www.twitter.com/ericsson
www.facebook.com/ericsson
www.linkedin.com/company/ericsson

MORE INFORMATION AT:
Ericsson Newsroom
media.relations@ericsson.com  (+46 10 719 69 92)
investor.relations@ericsson.com  (+46 10 719 00 00)

ABOUT ACTISTE®

Actiste® is the world's first complete IoT-health solution for monitoring and treating insulin-dependent diabetes, bringing together all required functions in a single connected device: blood sampling, blood glucose measurement and insulin injection. The device is based on patented technology for the collection of data on specified bio-markers and volumes of medication injected. Using state-of-the-art eSIM technology, provided by the industry leading ICT company Ericsson, the device has global out-of-the-box connectivity, making it completely independent of other devices to share health and treatment data. Actiste was awarded CE mark in September 2019.

The Actiste device is delivered as part of a subscription service. The service includes global connectivity, different levels of data sharing, continuous replenishment of everyday supplies and enables individualized coaching to optimize and improve treatments. https://actiste.com/

ABOUT BRIGHTER AB

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

ABOUT ERICSSON
Ericsson enables communications service providers to capture the full value of connectivity. The company’s portfolio spans Networks, Digital Services, Managed Services, and Emerging Business and is designed to help our customers go digital, increase efficiency and find new revenue streams. Ericsson’s investments in innovation have delivered the benefits of telephony and mobile broadband to billions of people around the world. The Ericsson stock is listed on Nasdaq Stockholm and on Nasdaq New York. www.ericsson.com